BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease

Roberts K.E., McElroy J.J., Wong W.P.K., Yen E., Widlitz A., Barst R.J., Knowles J.A., Morse J.H.

Source: Eur Respir J 2004; 24: 371-374

Journal Issue: September

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Roberts K.E., McElroy J.J., Wong W.P.K., Yen E., Widlitz A., Barst R.J., Knowles J.A., Morse J.H.. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 2004; 24: 371-374

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Pulmonary arterial hypertension associated with congenital heart disease Source: Eur Respir Rev 2012 21: 328-337 Year: 2012
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease Source: Eur Respir Rev 2009; 18: 154-161 Year: 2009
Genetics of pulmonary hypertension: from bench to bedside Source: Eur Respir J 2002; 20: 741-749 Year: 2002
Managing pulmonary hypertension in patients with congenital heart disease Source: Eur Respir Mon 2012; 57: 71-81 Year: 2012
Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension Source: Eur Respir Rev 2010 19: 300-307 Year: 2010
Changing demographics of pulmonary arterial hypertension in congenital heart disease Source: Eur Respir Rev 2010 19: 308-313 Year: 2010
Double combination therapy in patients with pulmonary arterial hypertension associated with congenital heart defects Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011
Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012
TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020
Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation Source: Eur Respir J 2007; 30: Suppl. 51, 250s Year: 2007
Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives Source: Eur Respir J 2002; 20: 518-523 Year: 2002
T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease Source: Eur Respir J, 54 (2) 1900388; 10.1183/13993003.00388-2019 Year: 2019
Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient Source: Eur Respir Rev 2014; 23: 147-149 Year: 2014
Adult congenital heart disease and pulmonary hypertension: management of a complex case Source: Eur Respir Rev 2012 21: 362-364 Year: 2012
Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation Source: Eur Respir J 2012; 39: 1534-1535 Year: 2012
Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases Source: Eur Respir J 2008; 31: 343-348 Year: 2008